WEST INDIAN MEDICAL JOURNAL, cilt.65, sa.3, ss.543-550, 2016 (SCI-Expanded)
Introduction: Head and neck cancer patients treated with radiotherapy suffer severe side-effects during and following their treatment. Efforts to decrease toxicity of irradiation to normal tissue, organs and cells have led to a search for cytoprotective agent. Investigations for effective and non-toxic compounds with radioprotective capability led to increasing interest in antioxidant such as thymoquinone (TQ).